<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ramsay JM</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>CDC HHS</funding><pagination>1181-1191</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8855920</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Childhood cancer survivors are at higher risk of human papillomavirus (HPV)-related second cancers than adolescents without cancer, yet their HPV vaccination uptake is lower. Using a statewide sample, we evaluated whether survivors are at higher risk of missed opportunities for concomitant HPV vaccination.&lt;h4>Methods&lt;/h4>From statewide healthcare data, we identified encounters where vaccines were received. Concomitant HPV vaccine missed opportunities were defined as a vaccine encounter where the HPV vaccine was not administered, although eligibility criteria were met. From these encounters, our sample included 327 survivors identified from the Utah Cancer Registry, diagnosed 2000-2016 at ages 0-9, and a birth year and sex-matched sample without cancer from the general popul</pubmed_abstract><journal>Cancer medicine</journal><pubmed_title>Missed opportunities for concomitant HPV vaccination among childhood cancer survivors.</pubmed_title><pmcid>PMC8855920</pmcid><funding_grant_id>NU58DP006320</funding_grant_id><funding_grant_id>R03 CA216174</funding_grant_id><funding_grant_id>HHSN261201800016I</funding_grant_id><pubmed_authors>Ramsay JM</pubmed_authors><pubmed_authors>Kaddas HK</pubmed_authors><pubmed_authors>Ou JY</pubmed_authors><pubmed_authors>Kepka D</pubmed_authors><pubmed_authors>Kirchhoff AC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Missed opportunities for concomitant HPV vaccination among childhood cancer survivors.</name><description>&lt;h4>Purpose&lt;/h4>Childhood cancer survivors are at higher risk of human papillomavirus (HPV)-related second cancers than adolescents without cancer, yet their HPV vaccination uptake is lower. Using a statewide sample, we evaluated whether survivors are at higher risk of missed opportunities for concomitant HPV vaccination.&lt;h4>Methods&lt;/h4>From statewide healthcare data, we identified encounters where vaccines were received. Concomitant HPV vaccine missed opportunities were defined as a vaccine encounter where the HPV vaccine was not administered, although eligibility criteria were met. From these encounters, our sample included 327 survivors identified from the Utah Cancer Registry, diagnosed 2000-2016 at ages 0-9, and a birth year and sex-matched sample without cancer from the general popul</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-04T08:58:14.829Z</modification><creation>2025-04-04T08:58:14.829Z</creation></dates><accession>S-EPMC8855920</accession><cross_references><pubmed>35032104</pubmed><doi>10.1002/cam4.4492</doi></cross_references></HashMap>